AgreeAHI pt btw 5-20 may benefit completely. Nice - but...

  1. 53 Posts.
    lightbulb Created with Sketch. 4
    Agree
    AHI pt btw 5-20 may benefit completely. Nice - but nevertheless relative benign in terms of RMD.

    ResMed (RMD.US)

    Seneste slutkurs: 152.15 (+4.84), 15. nov 2023

    Se anbefaling




    ResMed (RMD) - Teknisk analyse - US Stocks - Investtech
    Automatic technical analysis. Medium term, 15 Nov 2023
    ResMed has broken the falling trend channel in the medium term, which initially indicates a weaker falling rate. The stock gave a buy signal from a double-bottom formation on the break through the resistance at 150. Further rise to 165 or more is signaled. The stock has support at approximately $135 and resistance at approximately $207.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$38.62
Change
-0.290(0.75%)
Mkt cap ! $22.47B
Open High Low Value Volume
$38.84 $38.89 $38.51 $33.76M 871.8K

Buyers (Bids)

No. Vol. Price($)
5 3876 $38.55
 

Sellers (Offers)

Price($) Vol. No.
$38.68 72 1
View Market Depth
Last trade - 16.10pm 19/06/2025 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.